152 related articles for article (PubMed ID: 17070052)
1. ARDent about acetylation and deacetylation in hypoxia signalling.
Bilton R; Trottier E; Pouysségur J; Brahimi-Horn MC
Trends Cell Biol; 2006 Dec; 16(12):616-21. PubMed ID: 17070052
[TBL] [Abstract][Full Text] [Related]
2. Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1alpha protein by recruiting histone deacetylase 1.
Yoo YG; Kong G; Lee MO
EMBO J; 2006 Mar; 25(6):1231-41. PubMed ID: 16511565
[TBL] [Abstract][Full Text] [Related]
3. Purified recombinant hARD1 does not catalyse acetylation of Lys532 of HIF-1alpha fragments in vitro.
Murray-Rust TA; Oldham NJ; Hewitson KS; Schofield CJ
FEBS Lett; 2006 Apr; 580(8):1911-8. PubMed ID: 16500650
[TBL] [Abstract][Full Text] [Related]
4. Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor (HIF)-1alpha and is not induced by hypoxia or HIF.
Bilton R; Mazure N; Trottier E; Hattab M; Déry MA; Richard DE; Pouysségur J; Brahimi-Horn MC
J Biol Chem; 2005 Sep; 280(35):31132-40. PubMed ID: 15994306
[TBL] [Abstract][Full Text] [Related]
5. Interaction between HIF-1 alpha (ODD) and hARD1 does not induce acetylation and destabilization of HIF-1 alpha.
Arnesen T; Kong X; Evjenth R; Gromyko D; Varhaug JE; Lin Z; Sang N; Caro J; Lillehaug JR
FEBS Lett; 2005 Nov; 579(28):6428-32. PubMed ID: 16288748
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor-1alpha obstructs a Wnt signaling pathway by inhibiting the hARD1-mediated activation of beta-catenin.
Lim JH; Chun YS; Park JW
Cancer Res; 2008 Jul; 68(13):5177-84. PubMed ID: 18593917
[TBL] [Abstract][Full Text] [Related]
7. Targeting tumor angiogenesis with histone deacetylase inhibitors.
Ellis L; Hammers H; Pili R
Cancer Lett; 2009 Aug; 280(2):145-53. PubMed ID: 19111391
[TBL] [Abstract][Full Text] [Related]
8. Characterization of ARD1 variants in mammalian cells.
Kim SH; Park JA; Kim JH; Lee JW; Seo JH; Jung BK; Chun KH; Jeong JW; Bae MK; Kim KW
Biochem Biophys Res Commun; 2006 Feb; 340(2):422-7. PubMed ID: 16376303
[TBL] [Abstract][Full Text] [Related]
9. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
Hutt DM; Roth DM; Marchal C; Bouchecareilh M
Methods Mol Biol; 2017; 1510():77-91. PubMed ID: 27761814
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of the human ARD1-NATH protein acetyltransferase complex.
Arnesen T; Anderson D; Baldersheim C; Lanotte M; Varhaug JE; Lillehaug JR
Biochem J; 2005 Mar; 386(Pt 3):433-43. PubMed ID: 15496142
[TBL] [Abstract][Full Text] [Related]
11. Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization.
Fischer C; Leithner K; Wohlkoenig C; Quehenberger F; Bertsch A; Olschewski A; Olschewski H; Hrzenjak A
Mol Cancer; 2015 Jan; 14():4. PubMed ID: 25608569
[TBL] [Abstract][Full Text] [Related]
12. [Assay for inhibitory activity of histone deacetylase].
Yoshida M
Gan To Kagaku Ryoho; 2004 Apr; 31(4):507-11. PubMed ID: 15114691
[TBL] [Abstract][Full Text] [Related]
13. The Antiangiogenesis Role of Histone Deacetylase Inhibitors: Their Potential Application to Tumor Therapy and Tissue Repair.
Deng B; Luo Q; Halim A; Liu Q; Zhang B; Song G
DNA Cell Biol; 2020 Feb; 39(2):167-176. PubMed ID: 31808715
[TBL] [Abstract][Full Text] [Related]
14. Protein deacetylases: enzymes with functional diversity as novel therapeutic targets.
Yoshida M; Shimazu T; Matsuyama A
Prog Cell Cycle Res; 2003; 5():269-78. PubMed ID: 14593721
[TBL] [Abstract][Full Text] [Related]
15. Acetylation of proteins as novel target for antitumor therapy: review article.
Di Gennaro E; Bruzzese F; Caraglia M; Abruzzese A; Budillon A
Amino Acids; 2004 Jul; 26(4):435-41. PubMed ID: 15290351
[TBL] [Abstract][Full Text] [Related]
16. Expression, crystallization and preliminary X-ray crystallographic analyses of two N-terminal acetyltransferase-related proteins from Thermoplasma acidophilum.
Han SH; Ha JY; Kim KH; Oh SJ; Kim DJ; Kang JY; Yoon HJ; Kim SH; Seo JH; Kim KW; Suh SW
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Nov; 62(Pt 11):1127-30. PubMed ID: 17077495
[TBL] [Abstract][Full Text] [Related]
17. Autoacetylation regulates differentially the roles of ARD1 variants in tumorigenesis.
Seo JH; Park JH; Lee EJ; Vo TT; Choi H; Jang JK; Wee HJ; Ahn BJ; Cha JH; Shin MW; Kim KW
Int J Oncol; 2015 Jan; 46(1):99-106. PubMed ID: 25338643
[TBL] [Abstract][Full Text] [Related]
18. Acetylation and deacetylation of Cdc25A constitutes a novel mechanism for modulating Cdc25A functions with implications for cancer.
Lozada EM; Andrysik Z; Yin M; Redilla N; Rice K; Stambrook PJ
Oncotarget; 2016 Apr; 7(15):20425-39. PubMed ID: 26967250
[TBL] [Abstract][Full Text] [Related]
19. Characterization of hARD2, a processed hARD1 gene duplicate, encoding a human protein N-alpha-acetyltransferase.
Arnesen T; Betts MJ; Pendino F; Liberles DA; Anderson D; Caro J; Kong X; Varhaug JE; Lillehaug JR
BMC Biochem; 2006 Apr; 7():13. PubMed ID: 16638120
[TBL] [Abstract][Full Text] [Related]
20. Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha.
Qian DZ; Kachhap SK; Collis SJ; Verheul HM; Carducci MA; Atadja P; Pili R
Cancer Res; 2006 Sep; 66(17):8814-21. PubMed ID: 16951198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
